NB1, SH-SY5Y, CLBGA, NBL-S, and H3122 cells were cultured in complete medium and treated for the indicated time points with inhibitor (TAE684, LDK378, crizotinib, lorlatinib, LY294002, or U0126) as indicated, with their respective IC50 values reported. Control cells were treated with similar amount of DMSO as the treated cultures (0.1% DMSO). IGF-1 and insulin stimulations were performed using 100 ng/ml for 10 min after ALK inhibitor pretreatment. Cell lysates, protein concentration determination, and Western blotting were carried out as previously described (29).

注意:以上内容是从某篇研究文章中自动提取的,可能无法正确显示。



Q&A
请登录并在线提交您的问题
您的问题将发布在Bio-101网站上。我们会将您的问题发送给本研究方案的作者和具有相关研究经验的Bio-protocol成员。我们将通过您的Bio-protocol帐户绑定邮箱进行消息通知。